Imaging axonal damage of normal-appearing white matter in multiple sclerosis

Brain : a Journal of Neurology
L FuD L Arnold

Abstract

The current study was designed to determine the relative distribution of decreases of N-acetylasparate (NAA), a marker of axonal damage, between lesions and normal-appearing white matter of patients with established multiple sclerosis and to test for associations between changes in the ratio of NAA to creatine/phosphocreatine (NAA:Cr) in those compartments and changes in disability. Data were collected from a 30-month longitudinal study of 28 patients with either a relapsing course with partial remissons and no progression between attacks (relapsing/remitting) (11 patients) or a course of progressively increasing disability, following a period of relapsing/remitting disease (secondary progressive) (17 patients). Proton magnetic resonance spectroscopic imaging (MRSI) and conventional MRI examinations were performed at 6-8-month intervals with concurrent clinical assessments of disability. General linear models were used to test associations between MRSI, MRI, lesion volume and clinical data. Analysis confirmed that the NAA:Cr ratio is lower in lesions than in the normal-appearing white matter (-15.3% in relapsing/remitting multiple sclerosis and -8.8% in secondary progressive multiple sclerosis). The lower NAA:Cr ratio per unit ...Continue Reading

Citations

Oct 19, 1999·Microscopy Research and Technique·A S DePina, G M Langford
Nov 19, 2002·Journal of Neurobiology·Young-Hwan JoLorna W Role
Mar 12, 1998·Italian Journal of Neurological Sciences·D L Arnold, N De Stefano
Jul 2, 2003·Neurotoxicity Research·Carl Bjartmar, Bruce D Trapp
Nov 15, 2002·International Journal of Hematology·Richard K BurtAlberto M Marmont
Jun 1, 2011·Acta Neuropathologica·Richard ReynoldsOwain Howell
Oct 29, 2005·Journal of Neurology·Massimo Filippi, Maria Assunta Rocca
Jan 23, 2009·Journal of Neurology·Denis Bernardi BichuettiAlberto Gabbai
Jun 11, 2011·Journal of Neurology·David PalingDavid Miller
Apr 17, 2013·Journal of Neurology·Douglas L ArnoldSamson Antel
Mar 20, 2002·Current Neurology and Neuroscience Reports·B Kalman, F D Lublin
Apr 15, 2003·Current Neurology and Neuroscience Reports·Kottil W Rammohan
May 10, 2007·Current Neurology and Neuroscience Reports·Hans Lassmann
Aug 12, 2009·Current Neurology and Neuroscience Reports·Kimmy G SuMichael Forte
Jan 11, 2003·Current Treatment Options in Neurology·John R. CorboyElliot M. Frohman
Mar 9, 2004·Brain Research. Brain Research Reviews·Amy J Ross, Perminder S Sachdev
Mar 10, 2004·Neurobiology of Disease·Jacques De KeyserNadine Wilczak
Jul 4, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Elaine HolmesSarah J Tabrizi
May 17, 2005·Physical Medicine and Rehabilitation Clinics of North America·Jack H Simon
Aug 8, 2001·Journal of the Neurological Sciences·J de SezeP Vermersch
Sep 6, 2001·Journal of the Neurological Sciences·X Lin, L D Blumhardt
May 9, 2002·Journal of the Neurological Sciences·Douglas R Jeffery
May 9, 2002·Journal of the Neurological Sciences·Lalitha VaithianatharLance D Blumhardt
Feb 1, 2003·Journal of the Neurological Sciences·C BjartmarB D Trapp
Aug 28, 1999·Journal of the Neurological Sciences·P A BrexD H Miller
Dec 3, 1999·Journal of the Neurological Sciences·G ComiM Filippi
Dec 22, 1999·Journal of the Neurological Sciences·M Rovaris, M Filippi
Dec 22, 1999·Journal of the Neurological Sciences·T A YousryM Filippi
Dec 22, 1999·Journal of the Neurological Sciences·G ComiM Filippi
Nov 26, 1999·Life Sciences·L Van Den BoschW Robberecht
May 30, 2001·Lancet·G ComiUNKNOWN Early Treatment of Multiple Sclerosis Study Group
Jul 30, 1999·Journal of Neuroimmunology·B D TrappA Chang
Feb 23, 2000·Journal of Neuroimmunology·A AlcázarJ C Alvarez-Cermeño
May 15, 2002·Brain Research. Molecular Brain Research·J A BlackS G Waxman
Jul 20, 2002·Clinical Neurology and Neurosurgery·Ariel Miller, Yanina Galboiz
Jul 20, 2002·Clinical Neurology and Neurosurgery·Nikolaos Grigoriadis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.